02:08 PM EDT, 05/14/2025 (MT Newswires) -- Grail (GRAL) sank 21% amid heavy trading after the firm reported Q1 revenue that trailed analysts' estimates.

More than 3.9 million shares traded intraday compared with a daily average of about 1.46 million.

Germany's Deutsche Bank adjusted the share price target for Moderna ( MRNA ) to $28 from $35.

Shares of the COVID-19 vaccine manufacturer were down 5% after midday, with trading volume climbing to over 6.8 million from a daily average of about 10.1 million.

Endava ( DAVA ) retreated intraday after reporting fiscal Q3 revenue below market expectations and cutting its full-year 2025 revenue and adjusted earnings guidance.

Shares slumped 31% as intraday trading volume rose to over 4.4 million versus a daily average of about 574,000.

Price: 34.01, Change: -8.89, Percent Change: -20.72